Literature DB >> 32869693

IgG deposits in the mesangium and capillary loops predict poor renal outcome in patients with IgA nephropathy: a single-center retrospective study.

Siqi Peng1, Wen Lu1, Xiao Jiang1, Xingxin Xu1, Yonggui Wu1.   

Abstract

BACKGROUND: Glomerular IgG deposition in patients with IgA nephropathy (IgAN) has been shown to be associated with poor renal survival; however, most published studies to date are too small-scale and inconsistent to provide guidance for clinical practice.
METHODS: Based on renal biopsy findings, 742 patients were divided into the following groups: (i) IgA deposition alone (IgA) vs IgA + IgG deposition (IgA + IgG) and (ii) IgG co-deposition confined to the mesangium vs mesangium + capillary loops (CLs). The clinicopathological variables at biopsy and renal outcome were assessed.
RESULTS: Of the 742 patients, 182 had IgG co-deposition and 51 had IgG deposits in the mesangium + CLs. Patients with IgG co-deposition were associated with severe clinical and pathological lesions, especially those with a location of IgG deposits in the mesangium +CLs. Kaplan-Meier analysis revealed that a lower renal cumulative survival rate was present in both patients with IgG co-deposition and those with a location of IgG deposits in the mesangium + CLs (all p < 0.05). Moreover, patients with a higher intensity of glomerular IgG deposits or C3 deposits or C1q deposits were also associated with a lower survival rate. A multivariate Cox regression model identified the location of IgG deposits in the mesangium + CLs as an independent risk factor for poor prognosis (HR, 2.11; 95% CI: 1.06-4.18; p = 0.005).
CONCLUSIONS: Glomerular IgG co-deposition and the location of glomerular IgG deposits in the mesangium + CLs were both associated with adverse renal outcomes, but only the location of glomerular IgG deposits in the CLs was an independent risk factor for poor prognosis in IgAN.

Entities:  

Keywords:  IgA nephropathy; IgG co-deposition; IgG deposit location; renal pathology

Mesh:

Substances:

Year:  2020        PMID: 32869693      PMCID: PMC7946043          DOI: 10.1080/0886022X.2020.1811120

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  42 in total

1.  Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort.

Authors:  Shubha S Bellur; Stéphan Troyanov; H Terence Cook; Ian S D Roberts
Journal:  Nephrol Dial Transplant       Date:  2011-01-27       Impact factor: 5.992

2.  Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy.

Authors:  G-S Li; H Zhang; J-C Lv; Y Shen; H-Y Wang
Journal:  Kidney Int       Date:  2007-01-17       Impact factor: 10.612

Review 3.  Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.

Authors:  Hernán Trimarchi; Jonathan Barratt; Daniel C Cattran; H Terence Cook; Rosanna Coppo; Mark Haas; Zhi-Hong Liu; Ian S D Roberts; Yukio Yuzawa; Hong Zhang; John Feehally
Journal:  Kidney Int       Date:  2017-03-22       Impact factor: 10.612

4.  Determinants of immune complex-mediated glomerulonephritis.

Authors:  J W Fries; D L Mendrick; H G Rennke
Journal:  Kidney Int       Date:  1988-09       Impact factor: 10.612

5.  International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.

Authors:  K Solez; R A Axelsen; H Benediktsson; J F Burdick; A H Cohen; R B Colvin; B P Croker; D Droz; M S Dunnill; P F Halloran
Journal:  Kidney Int       Date:  1993-08       Impact factor: 10.612

6.  Idiopathic IgA nephropathy.

Authors:  J L Rodicio
Journal:  Kidney Int       Date:  1984-04       Impact factor: 10.612

7.  Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.

Authors:  Hiroko Odani; Koichiro Yamamoto; Sachiko Iwayama; Hitoo Iwase; Akihiko Takasaki; Kazuo Takahashi; Yoshiro Fujita; Satoshi Sugiyama; Yoshiyuki Hiki
Journal:  J Nephrol       Date:  2010 Jan-Feb       Impact factor: 3.902

8.  IgA nephropathy: morphologic predictors of progressive renal disease.

Authors:  S M Lee; V M Rao; W A Franklin; M S Schiffer; A J Aronson; B H Spargo; A I Katz
Journal:  Hum Pathol       Date:  1982-04       Impact factor: 3.466

9.  Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.

Authors:  M H Tao; R I Smith; S L Morrison
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

10.  Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy.

Authors:  Youxia Liu; Jie Zheng; Junya Jia; Hongfen Li; Shuiyi Hu; Yujia Lin; Tiekun Yan
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.